MedInvest Semiannual MedTech, AI, and Digital Health Conference Scheduled For December 10-11, 2024 in NYC

MedInvest, a leading healthcare, biotech, and medtech media and conference company, scheduled its semiannual MedTech, AI, and Digital Health Conference for December 10-11, 2024 in New York City. Goodwin Law Firm and the National Institutes of Health will be presenting partners of the event.

The conference is expected to attract 125+ investors spanning venture and public funds, family offices, strategics, and government and non-profit grant making entities and over 50 presenting companies. The two-day event will consist of half a dozen talks by KOLs and investor panels.

During, before and after the conference for two weeks, meetings will be facilitated both in person and virtually via the conference’s partnering system.

Speakers Include:

Paul LaViolette, General Partner, SV Health | Former COO and President International, Boston Scientific

Manny Villafana, Founder St. Jude Medical and CPI/Guidant | CEO and Founder, Medical 21

Prem Tumkosit, Managing Partner, Boundless Health Capital | Former Managing Director, Merck Global Health Innovation Fund

David Neustaedter, Pd.D., Venture Partner, Deerfield Management​

Allan Gobbs, Managing Partner, ATEM Capital

Dr. Victoria Manax, Managing Partner, Eckuity Capital

Deborah Zajac, Managing Director, Cerity Partners Ventures

Dr. Michael Salgaller, Director Invention Development and Marketing Unit (IDMU), NCI Tech Transfer

Steven Ferguson, Deputy Director, Licensing and Entrepreneurship, National Institutes of Health

Steven Tjoe, Partner, Goodwin

Mayan Katz, Partner, Goodwin